tm logo
ORILISSA
Live/Registered
REGISTERED

on 27 Nov 2018

Last Applicant/ Owned by

THISTLE HOUSE, 4 BURNABY STREET

HAMILTON

BM

HM 11

Serial Number

87104202 filed on 14th Jul 2016

Registration Number

5617902 registered on 27th Nov 2018

in the Principal Register

Correspondent Address

Sonali Srivastava

Sonali Srivastava ABBVIE INC.

NORTH CHICAGO, IL 60064

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ORILISSA

pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


Class [005]
Pharmaceutical Products


pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders


First Use Date in General

24th Jul 2018

First Use Date in Commerce

24th Jul 2018

Mark Details


Serial Number

No 87104202

Mark Type

No Service/Collective Mark

Attorney Docket Number

No ABVT68741

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
18th Nov 2024TEAS SECTION 8 RECEIVED
27th Nov 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10th Mar 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
27th Nov 2018REGISTERED-PRINCIPAL REGISTER
23rd Oct 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
22nd Oct 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
17th Oct 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
17th Oct 2018STATEMENT OF USE PROCESSING COMPLETE
20th Sep 2018USE AMENDMENT FILED
20th Sep 2018TEAS STATEMENT OF USE RECEIVED